AIS Insider Trading Activity and SEC Form 4 Filings
AIS insider trading summary
No open-market insider purchases or sales of Antares Pharma, Inc. (AIS) have been reported on SEC Form 4 in the past 12 months.
Latest AIS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 30, 2012 | Anton Gueth | Director | Sell | $249K (87,500 @ $2.85) |
| Dec 22, 2011 | Leonard S Jacob | Director | Buy | $9K (5,000 @ $1.79) |
| Aug 12, 2011 | Leonard S Jacob | Director | Buy | $4K (2,000 @ $2.06) |
| Apr 13, 2011 | Leonard S Jacob | Director | Buy | $16K (10,000 @ $1.58) |
| Mar 21, 2011 | Thomas J Garrity | Director | Buy | $5K (3,000 @ $1.63) |
| Mar 18, 2011 | Thomas J Garrity | Director | Buy | $11K (7,000 @ $1.58) |
| Dec 7, 2010 | Dario Carrara | Senior Vice President (1) | Sell | $104K (68,750 @ $1.51) |
| Sep 27, 2010 | Anton Gueth | Director | Buy | $11K (8,000 @ $1.41) |
| Aug 24, 2010 | Paul K Wotton | President and CEO | Buy | $15K (10,000 @ $1.50) |
| Aug 16, 2010 | Leonard S Jacob | Director | Buy | $8K (5,000 @ $1.59) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.